Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol
Files in This Item:
File | Size | Format | |
---|---|---|---|
Download | Brayden_Researchgate_21052015.docx | 534.74 kB | Microsoft Word |
Title: | Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol | Authors: | Brayden, David James; Maher, Sam; Bahar, Bojlul; Walsh, Edwin G. | Permanent link: | http://hdl.handle.net/10197/6622 | Date: | Aug-2015 | Online since: | 2016-05-27T01:00:13Z | Abstract: | Epithelial damage caused by intestinal permeation enhancers is a source of debate over their safety. The medium chain fatty acid, sodium caprate (C10), causes reversible membrane perturbation at high dose levels required for efficacy in vivo, so the aim was to model it in vitro. Exposure of Caco-2 monolayers to 8.5mM C10 for 60min followed by incubation in fresh buffer led to (i) recovery in epithelial permeability (i.e. transepithelial electrical resistance (TEER) and apparent permeability coefficient (Papp) of [(14)C]-mannitol), (ii) recovery of cell viability parameters (monolayer morphology, plasma membrane potential, mitochondrial membrane potential, and intracellular calcium) and (iii) reduction in mRNA expression associated with inflammation (IL-8). Pre-incubation of monolayers with a mucosal prostaglandin cytoprotectant was attempted in order to further decipher the mechanism of C10. Misoprostol (100nM), inhibited C10-induced changes in monolayer parameters, an effect that was partially attenuated by the EP1 receptor antagonist, SC51322. In rat isolated intestinal tissue mucosae and in situ loop instillations, C10-induced respective increases in the [(14)C]-mannitol Papp and the AUC of FITC-dextran 4000 (FD-4) were similarly inhibited by misoprostol, with accompanying morphological damage spared. These data support a temporary membrane perturbation effect of C10, which is linked to its capacity to mainly increase paracellular flux, but which can be prevented by pre-exposure to misoprostol. | Funding Details: | Irish Research Council Science Foundation Ireland |
Type of material: | Journal Article | Publisher: | Elsevier | Journal: | European Journal of Pharmaceutics and Biopharmaceutics | Volume: | 94 | Start page: | 194 | End page: | 206 | Copyright (published version): | 2015 Elsevier | Keywords: | Oral peptide delivery; Medium chain fatty acids; Sodium caprate; Caco-2 monolayers; Intestinal permeation enhancers; Cytotoxicity assays | DOI: | 10.1016/j.ejpb.2015.05.013 | Language: | en | Status of Item: | Peer reviewed | This item is made available under a Creative Commons License: | https://creativecommons.org/licenses/by-nc-nd/3.0/ie/ |
Appears in Collections: | Irish Drug Delivery Network Research Collection Veterinary Medicine Research Collection |
Show full item record
SCOPUSTM
Citations
20
21
Last Week
0
0
Last month
0
0
checked on Sep 12, 2020
Page view(s) 5
2,741
Last Week
3
3
Last month
17
17
checked on May 21, 2022
Download(s) 50
507
checked on May 21, 2022
Google ScholarTM
Check
Altmetric
If you are a publisher or author and have copyright concerns for any item, please email research.repository@ucd.ie and the item will be withdrawn immediately. The author or person responsible for depositing the article will be contacted within one business day.